Study Stopped
Study never initiated.
A Comparative Study of the Air-Q ILA and the ILMA for Ventilation and Intubation
1 other identifier
observational
N/A
1 country
1
Brief Summary
The objective of this study is to determine if the glottic view obtained with the air-Q Intubating Laryngeal Airway (air-Q ILA, Cookgas LLC®, Mercury Medical®, Clearwater, FL, USA) is better than that obtained with the traditionally used intubating laryngeal mask airway (LMA FastrachTM or ILMA, LMA North America Inc., San Diego, CA). The study will also compare effectiveness of ventilation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 23, 2010
CompletedFirst Posted
Study publicly available on registry
September 27, 2010
CompletedStudy Start
First participant enrolled
January 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2011
CompletedJuly 18, 2018
July 1, 2018
Same day
September 23, 2010
July 17, 2018
Conditions
Study Arms (2)
air-Q Intubating Laryngeal Airway
LMA FastrachTM or ILMA
Eligibility Criteria
Healthy ASA class I and II patients scheduled for elective surgery under general anesthesia requiring the use of the LMA.
You may qualify if:
- healthy ASA class I and II patients scheduled for elective surgery under general anesthesia requiring the use of the LMA
You may not qualify if:
- history of acid reflux,
- a BMI ≥ 40kg.m-2,
- require endotracheal intubation,
- have predictors of difficult intubation,
- not candidates for insertion of an ILMA or LMA, including a mouth opening of less than 2.5 cm,
- cannot consent to the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
QEII Health Sciences Centre
Halifax, Nova Scotia, B3H 2Y9, Canada
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD FRCPC
Study Record Dates
First Submitted
September 23, 2010
First Posted
September 27, 2010
Study Start
January 1, 2011
Primary Completion
January 1, 2011
Study Completion
January 1, 2011
Last Updated
July 18, 2018
Record last verified: 2018-07